BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
21.82
+0.89 (4.25%)
At close: Feb 6, 2026, 4:00 PM EST
21.78
-0.04 (-0.18%)
After-hours: Feb 6, 2026, 5:43 PM EST
BrainsWay Employees
BrainsWay had 120 employees as of December 31, 2024. The number of employees decreased by 14 or -10.45% compared to the previous year.
Employees
120
Change (1Y)
-14
Growth (1Y)
-10.45%
Revenue / Employee
$409,117
Profits / Employee
$52,067
Market Cap
419.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 120 | -14 | -10.45% |
| Dec 31, 2023 | 134 | 0 | - |
| Dec 31, 2022 | 134 | 16 | 13.56% |
| Dec 31, 2021 | 118 | 18 | 18.00% |
| Dec 31, 2020 | 100 | -7 | -6.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,616 |
| Viemed Healthcare | 1,380 |
| Bioventus | 950 |
| Standard BioTools | 818 |
| Cerus | 630 |
| Pacific Biosciences of California | 575 |
| OrthoPediatrics | 562 |
| RxSight | 498 |
BWAY News
- 18 days ago - BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™ - GlobeNewsWire
- 27 days ago - BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD) - GlobeNewsWire
- 4 weeks ago - BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™ - GlobeNewsWire
- 6 weeks ago - BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™ - GlobeNewsWire
- 2 months ago - BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript - Seeking Alpha
- 2 months ago - BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025 - GlobeNewsWire
- 2 months ago - BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder - GlobeNewsWire
- 3 months ago - BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewsWire